Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1991 Feb;54(2):110–115. doi: 10.1136/jnnp.54.2.110

SPECT, MRI and cognitive functions in multiple sclerosis.

C Pozzilli 1, D Passafiume 1, S Bernardi 1, P Pantano 1, C Incoccia 1, S Bastianello 1, L Bozzao 1, G L Lenzi 1, C Fieschi 1
PMCID: PMC1014343  PMID: 2019835

Abstract

Seventeen patients with relapsing remitting multiple sclerosis (MS) and mild physical disability had neuropsychological testing, magnetic resonance imaging (MRI) and single photon emission computerised tomography (SPECT) using technetium 99m (99mTc) hexamethyl-propyleneamine oxime (HMPAO). Performance in verbal fluency, naming and memory testing appeared to be impaired in MS patients compared with 17 age-sex and education matched normal controls. Weighted periventricular and confluent lesion scores and the width of the third ventricle, proved to be the most sensitive MRI measures in differentiating more cognitively impaired patients from those who were relatively unimpaired. Ratios of regional to whole brain activity, measured by SPECT, showed significant reduction in the frontal lobes and in the left temporal lobe of MS patients. A relationship was found between left temporal abnormality in 99mTc-HMPAO uptake and deficit in verbal fluency and verbal memory. Finally, asymmetrical lobar activity indicated a predominant left rather than right temporo-parietal involvement.

Full text

PDF
110

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bastianello S., Pozzilli C., Bernardi S., Bozzao L., Fantozzi L. M., Buttinelli C., Fieschi C. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology. 1990 Apr;40(4):591–595. doi: 10.1212/wnl.40.4.591. [DOI] [PubMed] [Google Scholar]
  2. Beatty W. W., Goodkin D. E., Monson N., Beatty P. A. Cognitive disturbances in patients with relapsing remitting multiple sclerosis. Arch Neurol. 1989 Oct;46(10):1113–1119. doi: 10.1001/archneur.1989.00520460103020. [DOI] [PubMed] [Google Scholar]
  3. Bonte F. J., Ross E. D., Chehabi H. H., Devous M. D., Sr SPECT study of regional cerebral blood flow in Alzheimer disease. J Comput Assist Tomogr. 1986 Jul-Aug;10(4):579–583. doi: 10.1097/00004728-198607000-00005. [DOI] [PubMed] [Google Scholar]
  4. Brooks D. J., Leenders K. L., Head G., Marshall J., Legg N. J., Jones T. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1984 Nov;47(11):1182–1191. doi: 10.1136/jnnp.47.11.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burns A., Philpot M. P., Costa D. C., Ell P. J., Levy R. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):248–253. doi: 10.1136/jnnp.52.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CHRISTENSEN E., HOJGAARD K. POLIODYSTROFIA CEREBRI PROGRESSIVA INFANTILIS. AN ENTITY? Acta Neurol Scand. 1964;40:21–40. doi: 10.1111/j.1600-0404.1964.tb04263.x. [DOI] [PubMed] [Google Scholar]
  7. Caine E. D., Bamford K. A., Schiffer R. B., Shoulson I., Levy S. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Arch Neurol. 1986 Mar;43(3):249–254. doi: 10.1001/archneur.1986.00520030039009. [DOI] [PubMed] [Google Scholar]
  8. Callanan M. M., Logsdail S. J., Ron M. A., Warrington E. K. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain. 1989 Apr;112(Pt 2):361–374. doi: 10.1093/brain/112.2.361. [DOI] [PubMed] [Google Scholar]
  9. Chayasirisobhon S., Walters B. Familial syndrome of deafness, myoclonus, and cerebellar ataxia. Neurology. 1984 Jan;34(1):78–79. doi: 10.1212/wnl.34.1.78. [DOI] [PubMed] [Google Scholar]
  10. Cummings J. L., Benson D. F. Subcortical dementia. Review of an emerging concept. Arch Neurol. 1984 Aug;41(8):874–879. doi: 10.1001/archneur.1984.04050190080019. [DOI] [PubMed] [Google Scholar]
  11. D'Antona R., Baron J. C., Samson Y., Serdaru M., Viader F., Agid Y., Cambier J. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain. 1985 Sep;108(Pt 3):785–799. doi: 10.1093/brain/108.3.785. [DOI] [PubMed] [Google Scholar]
  12. Filley C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Arch Neurol. 1989 Feb;46(2):157–161. doi: 10.1001/archneur.1989.00520380061013. [DOI] [PubMed] [Google Scholar]
  13. Frackowiak R. S., Pozzilli C., Legg N. J., Du Boulay G. H., Marshall J., Lenzi G. L., Jones T. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain. 1981 Dec;104(Pt 4):753–778. doi: 10.1093/brain/104.4.753. [DOI] [PubMed] [Google Scholar]
  14. Franklin G. M., Heaton R. K., Nelson L. M., Filley C. M., Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology. 1988 Dec;38(12):1826–1829. doi: 10.1212/wnl.38.12.1826. [DOI] [PubMed] [Google Scholar]
  15. Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Arch Neurol. 1989 Feb;46(2):162–167. doi: 10.1001/archneur.1989.00520380066014. [DOI] [PubMed] [Google Scholar]
  16. Goffinet A. M., De Volder A. G., Gillain C., Rectem D., Bol A., Michel C., Cogneau M., Labar D., Laterre C. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann Neurol. 1989 Feb;25(2):131–139. doi: 10.1002/ana.410250205. [DOI] [PubMed] [Google Scholar]
  17. Grant I., McDonald W. I., Trimble M. R., Smith E., Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1984 Mar;47(3):250–255. doi: 10.1136/jnnp.47.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Heaton R. K., Nelson L. M., Thompson D. S., Burks J. S., Franklin G. M. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol. 1985 Feb;53(1):103–110. doi: 10.1037//0022-006x.53.1.103. [DOI] [PubMed] [Google Scholar]
  19. Huber S. J., Paulson G. W., Shuttleworth E. C., Chakeres D., Clapp L. E., Pakalnis A., Weiss K., Rammohan K. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol. 1987 Jul;44(7):732–736. doi: 10.1001/archneur.1987.00520190040015. [DOI] [PubMed] [Google Scholar]
  20. Jambor K. L. Cognitive functioning in multiple sclerosis. Br J Psychiatry. 1969 Jul;115(524):765–775. doi: 10.1192/bjp.115.524.765. [DOI] [PubMed] [Google Scholar]
  21. Koopmans R. A., Li D. K., Grochowski E., Cutler P. J., Paty D. W. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol. 1989 Jan;25(1):74–81. doi: 10.1002/ana.410250112. [DOI] [PubMed] [Google Scholar]
  22. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444–1452. doi: 10.1212/wnl.33.11.1444. [DOI] [PubMed] [Google Scholar]
  23. Leonard J. P., Nowotnik D. P., Neirinckx R. D. Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM. J Nucl Med. 1986 Dec;27(12):1819–1823. [PubMed] [Google Scholar]
  24. Loewenstein D. A., Barker W. W., Chang J. Y., Apicella A., Yoshii F., Kothari P., Levin B., Duara R. Predominant left hemisphere metabolic dysfunction in dementia. Arch Neurol. 1989 Feb;46(2):146–152. doi: 10.1001/archneur.1989.00520380046012. [DOI] [PubMed] [Google Scholar]
  25. Lyon-Caen O., Jouvent R., Hauser S., Chaunu M. P., Benoit N., Widlöcher D., Lhermitte F. Cognitive function in recent-onset demyelinating diseases. Arch Neurol. 1986 Nov;43(11):1138–1141. doi: 10.1001/archneur.1986.00520110034010. [DOI] [PubMed] [Google Scholar]
  26. Medaer R., Nelissen E., Appel B., Swerts M., Geutjens J., Callaert H. Magnetic resonance imaging and cognitive functioning in multiple sclerosis. J Neurol. 1987 Dec;235(2):86–89. doi: 10.1007/BF00718015. [DOI] [PubMed] [Google Scholar]
  27. Miller D. H., Rudge P., Johnson G., Kendall B. E., Macmanus D. G., Moseley I. F., Barnes D., McDonald W. I. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain. 1988 Aug;111(Pt 4):927–939. doi: 10.1093/brain/111.4.927. [DOI] [PubMed] [Google Scholar]
  28. Ormerod I. E., Miller D. H., McDonald W. I., du Boulay E. P., Rudge P., Kendall B. E., Moseley I. F., Johnson G., Tofts P. S., Halliday A. M. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain. 1987 Dec;110(Pt 6):1579–1616. doi: 10.1093/brain/110.6.1579. [DOI] [PubMed] [Google Scholar]
  29. Peters A. M., Danpure H. J., Osman S., Hawker R. J., Henderson B. L., Hodgson H. J., Kelly J. D., Neirinckx R. D., Lavender J. P. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet. 1986 Oct 25;2(8513):946–949. doi: 10.1016/s0140-6736(86)90601-x. [DOI] [PubMed] [Google Scholar]
  30. Peyser J. M., Edwards K. R., Poser C. M., Filskov S. B. Cognitive function in patients with multiple sclerosis. Arch Neurol. 1980 Sep;37(9):577–579. doi: 10.1001/archneur.1980.00500580073013. [DOI] [PubMed] [Google Scholar]
  31. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  32. Pozzilli C., Pantano P., Bozzao L., Bernardi S., Carolei A., Fieschi C. Sequential computed tomography and 123I-HIPDM scans in multiple sclerosis with large plaque. A case report. Eur Neurol. 1987;27(2):88–91. doi: 10.1159/000116137. [DOI] [PubMed] [Google Scholar]
  33. Rao S. M., Glatt S., Hammeke T. A., McQuillen M. P., Khatri B. O., Rhodes A. M., Pollard S. Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. Arch Neurol. 1985 Jul;42(7):678–682. doi: 10.1001/archneur.1985.04060070068018. [DOI] [PubMed] [Google Scholar]
  34. Rao S. M., Hammeke T. A., McQuillen M. P., Khatri B. O., Lloyd D. Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol. 1984 Jun;41(6):625–631. doi: 10.1001/archneur.1984.04210080033010. [DOI] [PubMed] [Google Scholar]
  35. Rao S. M., Leo G. J., Haughton V. M., St Aubin-Faubert P., Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology. 1989 Feb;39(2 Pt 1):161–166. doi: 10.1212/wnl.39.2.161. [DOI] [PubMed] [Google Scholar]
  36. Rao S. M. Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol. 1986 Oct;8(5):503–542. doi: 10.1080/01688638608405173. [DOI] [PubMed] [Google Scholar]
  37. Reischies F. M., Baum K., Bräu H., Hedde J. P., Schwindt G. Cerebral magnetic resonance imaging findings in multiple sclerosis. Relation to disturbance of affect, drive, and cognition. Arch Neurol. 1988 Oct;45(10):1114–1116. doi: 10.1001/archneur.1988.00520340068014. [DOI] [PubMed] [Google Scholar]
  38. SCHUMACHER G. A., BEEBE G., KIBLER R. F., KURLAND L. T., KURTZKE J. F., MCDOWELL F., NAGLER B., SIBLEY W. A., TOURTELLOTTE W. W., WILLMON T. L. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS. Ann N Y Acad Sci. 1965 Mar 31;122:552–568. doi: 10.1111/j.1749-6632.1965.tb20235.x. [DOI] [PubMed] [Google Scholar]
  39. Staples D., Lincoln N. B. Intellectual impairment in multiple sclerosis and its relation to functional abilities. Rheumatol Rehabil. 1979 Aug;18(3):153–160. doi: 10.1093/rheumatology/18.3.153. [DOI] [PubMed] [Google Scholar]
  40. Young A. C., Saunders J., Ponsford J. R. Mental change as an early feature of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1976 Oct;39(10):1008–1013. doi: 10.1136/jnnp.39.10.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. van den Burg W., van Zomeren A. H., Minderhoud J. M., Prange A. J., Meijer N. S. Cognitive impairment in patients with multiple sclerosis and mild physical disability. Arch Neurol. 1987 May;44(5):494–501. doi: 10.1001/archneur.1987.00520170024017. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES